Bleeding events occurred substantially less often with the lower dose of aspirin, reported John Burn, MD, of Newcastle ...

Adjuvant aspirin did not reduce recurrence or improve survival in patients with CRC liver metastases, phase 3 data showed at ...

Too many people are missing out on a potentially life-changing opportunity to prevent cancer,” said Sir John Burn.

Taking a single, small dose of aspirin a day can prevent bowel cancer in people at high risk of the disease, according to the ...

Prof Sir John Burn, from Newcastle University, said he would ask health regulators to formally advise a low dose of 75mg be ...

CHICAGO — Daily adjuvant aspirin did not reduce disease recurrence for patients with colorectal cancer liver metastases and may increase risk for death, according to findings presented at ASCO ...

Researchers discovered that people who took just two standard aspirin tablets weekly experienced an 18 percent reduction in colorectal cancer risk compared to non-users.

Key Takeaways Aspirin reduced colorectal cancer recurrence risk by 50% in patients with PIK3CA mutations over three years. Mutations in the PI3K pathway predict aspirin response, broadening its use to ...

Lifestyle, Aspirin Use, and Colorectal Cancer Risk Previous research has shown a link between a person’s lifestyle habits—such as smoking and alcohol consumption —and their risk of CRC.

Past studies have linked aspirin use to lowering colorectal cancer risk. A study published in August 2021 reported that aspirin use was correlated to a reduction in overall risk of recurrence and ...

Overall, the risk of developing colorectal cancer over a 10-year period was 1.98% among participants who used aspirin regularly, compared with 2.95% for people who didn’t use aspirin regularly.

Aspirin is widely known for its heart attack prevention benefits, but a new study has also linked the common drug to a reduced risk of colorectal cancer. The study analyzed data from 107,655 men ...